Get started
Author

Tahmineh Safaie

ORCID: 0000-0002-2673-0998
Observed ORCID: 0000-0002-2673-0998
OpenAlex ID: A5070445146
Natural killer cells target and differentiate cancer stem-like cells/undifferentiated tumors: strategies to optimize their growth and expansion for effective cancer immunotherapy
2018 · Kawaljit Kaur, Milica Perišić Nanut, et al. · Current Opinion in Immunology · 69
ADCC against MICA/B Is Mediated against Differentiated Oral and Pancreatic and Not Stem-Like/Poorly Differentiated Tumors by the NK Cells; Loss in Cancer Patients due to Down-Modulation of CD16 Receptor
2021 · Kawaljit Kaur, Tahmineh Safaie, et al. · Cancers · 46
PDF
Normalization of serum B‐cell maturation antigen levels predicts overall survival among multiple myeloma patients starting treatment
2020 · Scott Jew, Tiffany Chang, et al. · British Journal of Haematology · 24
PDF
Estimating a normal reference range for serum B‐cell maturation antigen levels for multiple myeloma patients
2020 · Scott Jew, Sean Bujarski, et al. · British Journal of Haematology · 22
PDF
Baseline and Changes in Serum B-Cell Maturation Antigen Levels Rapidly Indicate Changes in Clinical Status Among Patients with Relapsed/Refractory Multiple Myeloma Starting New Therapy
2021 · Sean Bujarski, Kyle Udd, et al. · Targeted Oncology · 20
The effect of casein phosphopeptide amorphous calcium phosphate fluoride paste (CPP-ACPF) on oral and salivary conditions of patients undergoing chemotherapy: A randomized controlled clinical trial
2015 · Sepideh Banava, Mohammad Houshyari, et al. · Electronic physician · 14
PDF
Clinical Comparison of Dental Caries by DMFT and ICDAS Systems
2012 · Sepideh Banava, Melika Fattah, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 12
Ruxolitinib and methylprednisolone for treatment of patients with relapsed/refractory multiple myeloma
2022 · James R. Berenson, Daisy Martinez, et al. · British Journal of Haematology · 11
Baseline and Increases in Serum B-Cell Maturation Antigen Levels Rapidly Indicate Changes in Clinical Status Among Relapsed/Refractory Multiple Myeloma Patients Undergoing New Treatments
2019 · Sean Bujarski, Kyle Udd, et al. · Blood · 5
A Phase I Trial Evaluating the Addition of Lenalidomide to Patients with Relapsed/Refractory Multiple Myeloma Progressing on Ruxolitinib and Methylprednisolone
2024 · James R. Berenson, Andrea Limon, et al. · Targeted Oncology · 3
Normalization of Serum B-Cell Maturation Antigen Levels from Treatment Predicts Progression Free and Overall Survival in Multiple Myeloma Patients
2019 · Scott Kristian Jew, Tiffany Chang, et al. · Blood · 3
Normalization of Serum B-cell Maturation Antigen Levels Predicts Progression Free and Overall Survival in Multiple Myeloma Patients Starting Treatment
2019 · Scott Jew, Tiffany Chang, et al. · Clinical Lymphoma Myeloma & Leukemia · 3
Ruxolitinib and Methylprednisolone for Treatment of Patients with Relapsed/Refractory Multiple Myeloma
2022 · James R. Berenson, Daisy Martinez, et al. · Blood · 2
A Phase 1 Trial Evaluating the Addition of Lenalidomide to Relapsed/Refractory Multiple Myeloma Patients Progressing on Ruxolitinib and Methylprednisolone
2023 · James R Berenson, Andrea Limon, et al. · Blood · 1
PDF
Efficacy and Safety of Ruxolitinib and Steroids for Treating Patients with Relapsed or Refractory Multiple Myeloma
2021 · James R. Berenson, Daisy Martinez, et al. · Blood · 1
Changes in Serum B-Cell Maturation Antigen Levels Rapidly Predict Progression Free Survival among Multiple Myeloma Patients undergoing New Treatment
2019 · Sean Bujarski, Kyle Udd, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
An Anti-CD138-Targeted Interferon-Alpha Has Broad Efficacy in Solid Tumors Through Direct Tumor Cell Killing and Intratumoral Immune Modulation
2024 · Tahmineh Safaie, Kham R. Trinh, et al. · Journal of Interferon & Cytokine Research
Abstract 1581: Nammisomes: Preclinical validation of a platform for selective and synchronized delivery of novel immunotherapy prodrug combinations to tumors
2021 · David R. Stover, Dhruba Bharali, et al. · Cancer Research
Preferential induction of NK cell mediated Antibody Dependent Cellular Cytotoxicity (ADCC) against differentiated oral and pancreatic tumors expressing MICA/B
2018 · Tahmineh Safaie · eScholarship (California Digital Library)
PDF
Works count: 19
Citation count: 237
H-index: 8
I10-index: 8
Year
Topic
Type